相关实验视频

Updated: May 6, 2026

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

研究回顾和转录基因洞察到化吸入和疾病关联的甲

Jun Woo Kim¹, Min Seok Kim¹, Ha Ryong Kim²

¹Center for Respiratory Safety Research, Korea Institute of Toxicology, Jeongeup 56212, South Korea.

Ecotoxicology and environmental safety

|January 3, 2025

概括

吸入甲化物 (BKC) 可能引发呼吸系统疾病,但证据不足. 需要进一步的研究来理解BKC.

科学领域:

毒理学毒理学毒理学
环境健康环境健康
呼吸系统医学呼吸系统医学

背景情况:

消毒剂的使用增加,特别是在COVID-19期间,引起了人们对生物制剂吸入的担忧.
化 (BKC) 是一种常见的消毒剂,对其呼吸道和全身毒性的研究有限.
现有的文献表明,BKC暴露与呼吸系统疾病之间存在潜在联系,但证据不足.

研究的目的:

审查关于BKC呼吸系统毒性的文献.
使用体外气溶暴露模型研究BKC的毒理途径.
探索BKC暴露与呼吸道和心血管疾病之间的潜在联系.

主要方法:

关于BKC呼吸系统毒性的文献综述.
使用初级支气管上皮细胞的气溶暴露模型.
转录组分析以确定毒理途径中的差异表达基因 (DEGs).
与基因疾病关联数据库的集成.
对分泌的蛋白质进行系统性影响的分析.

主要成果:

在支气管细胞中,BKC暴露诱导了内质网膜 (ER) 应激,亡,线粒体功能障碍和上皮-介质细胞过渡 (EMT).
基因疾病关联分析表明,BKC与喘,COPD和肺纤维化之间存在潜在联系.
分泌蛋白质分析表明,BKC暴露可能对心血管有影响.

结论:

目前的证据表明,BKC可能会诱导呼吸系统疾病,但需要进一步的研究.
吸入BKC暴露可能会触发关键的毒理途径.
对BKC使用的长期健康影响和监管措施需要进一步调查.

关键词:

暴露于气溶中的气溶.甲化的含量是多少甲化吸入性毒性吸入性毒性肺部疾病肺部疾病

更多相关视频

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

相关概念视频

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Microbiota of the Respiratory Tract

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...